These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 17355216)

  • 21. Pilot dose-escalation study of caffeine plus ethanol (caffeinol) in acute ischemic stroke.
    Piriyawat P; Labiche LA; Burgin WS; Aronowski JA; Grotta JC
    Stroke; 2003 May; 34(5):1242-5. PubMed ID: 12690224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prospects of thrombolytic therapy for acute ischemic stroke].
    Nakashima T; Minematsu K
    Brain Nerve; 2009 Sep; 61(9):1003-12. PubMed ID: 19803399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Translational stroke research of the combination of thrombolysis and antioxidant therapy.
    Amaro S; Chamorro Á
    Stroke; 2011 May; 42(5):1495-9. PubMed ID: 21474803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombolysis for acute ischemic stroke--our experiences as part of SITS-MOST.
    Roje-Bedeković M; Vargek-Solter V; Corić L; Sabolek K; Breitenfeld T; Supanc V; Demarin V
    Acta Clin Croat; 2009 Sep; 48(3):287-93. PubMed ID: 20055250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute treatment for ischemic stroke in 2004.
    Mohammad YM; Divani AA; Kirmani JF; Harris-Lane P; Qureshi AI
    Emerg Radiol; 2004 Dec; 11(2):83-6. PubMed ID: 15309661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of acute ischemic stroke: recent progress.
    Tanahashi N; Fukuuchi Y
    Intern Med; 2002 May; 41(5):337-44. PubMed ID: 12058880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombolysis with alteplase 4.5-6 hours after acute ischemic stroke.
    Zhang B; Sun XJ; Ju CH
    Eur Neurol; 2011; 65(3):170-4. PubMed ID: 21372577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful intravenous thrombolysis in a patient with antiphospholipid syndrome, acute ischemic stroke and severe thrombocytopenia.
    Camara-Lemarroy CR; Infante-Valenzuela A; Andrade-Vazquez CJ; Enriquez-Noyola RV; Garcia-Valadez EA; Gongora-Rivera F
    Blood Coagul Fibrinolysis; 2016 Apr; 27(3):354-6. PubMed ID: 26575492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant human tissue-type plasminogen activator in the rat.
    Zhang L; Zhang ZG; Ding GL; Jiang Q; Liu X; Meng H; Hozeska A; Zhang C; Li L; Morris D; Zhang RL; Lu M; Chopp M
    Circulation; 2005 Nov; 112(22):3486-94. PubMed ID: 16316970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous Recombinant Tissue Plasminogen Activator Does Not Impact Mortality in Acute Ischemic Stroke at Any Time Point up to 6 Months: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials.
    Kumar G; Uhrig D; Fowler S; DeLaney MC; Alexandrov AV
    CNS Drugs; 2015 Aug; 29(8):659-67. PubMed ID: 26251162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ebselen, a seleno-organic antioxidant, is neuroprotective after embolic strokes in rabbits: synergism with low-dose tissue plasminogen activator.
    Lapchak PA; Zivin JA
    Stroke; 2003 Aug; 34(8):2013-8. PubMed ID: 12855833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Update on intravenous recombinant tissue plasminogen activator for acute ischemic stroke.
    Fugate JE; Rabinstein AA
    Mayo Clin Proc; 2014 Jul; 89(7):960-72. PubMed ID: 24775222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of fingolimod combined with alteplase in acute ischemic stroke and rehabilitation nursing.
    Liantao Z; Jing Z; Lingling L; Hua L
    Pak J Pharm Sci; 2019 Jan; 32(1(Special)):413-419. PubMed ID: 30852478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multicenter Study of Intravenous Recombinant Tissue Plasminogen Activator Infusion around Hiroshima, Japan: The Hiroshima Acute Stroke Retrospective and Prospective Registry Study.
    Aoki S; Hosomi N; Sueda Y; Kono T; Takamatsu K; Ohyama H; Torii T; Kitamura T; Nomura E; Noda K; Ohtsuki T; Matsumoto M;
    J Stroke Cerebrovasc Dis; 2015 Dec; 24(12):2747-53. PubMed ID: 26360972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of tissue plasminogen activator in acute ischemic stroke.
    Hatcher MA; Starr JA
    Ann Pharmacother; 2011 Mar; 45(3):364-71. PubMed ID: 21386027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous Thrombolysis in Unknown-Onset Stroke: Results From the Safe Implementation of Treatment in Stroke-International Stroke Thrombolysis Registry.
    Dorado L; Ahmed N; Thomalla G; Lozano M; Malojcic B; Wani M; Millán M; Tomek A; Dávalos A
    Stroke; 2017 Mar; 48(3):720-725. PubMed ID: 28174326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent progress in drug treatment for acute ischemic stroke.
    Devuyst G; Bogousslavsky J
    Cerebrovasc Dis; 2001; 11 Suppl 1():71-9. PubMed ID: 11244203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of thrombolytic therapy for stroke: a perspective.
    Lapchak PA
    Expert Opin Investig Drugs; 2002 Nov; 11(11):1623-32. PubMed ID: 12437508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Acute ischemic stroke: time is brain!].
    Larrue V
    Rev Prat; 2006 Sep; 56(13):1418-23. PubMed ID: 17002067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
    Power A; Epstein D; Cohen D; Bathula R; Devine J; Kar A; Taube D; Duncan N; Ames D
    Cerebrovasc Dis; 2013; 35(1):45-52. PubMed ID: 23428996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.